Kyongbo Pharmaceutical Co., Ltd
KRX:214390.KS
5010 (KRW) • At close July 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 4,127.75 | 4,477.057 | 6,348.48 | 4,290.311 | 11,439.285 | 6,768.829 | 4,985.877 | 6,403.652 | 4,580.309 | 4,404.474 | 6,952.959 |
| Short Term Investments
| 2,000 | 870 | 870 | -1,161.09 | 9,543.262 | -1,053.049 | -1,576.448 | -1,321.328 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 6,127.75 | 5,347.057 | 7,218.48 | 4,290.311 | 20,982.547 | 6,768.829 | 4,985.877 | 6,403.652 | 4,580.309 | 4,404.474 | 6,952.959 |
| Net Receivables
| 52,310.905 | 56,159.775 | 50,833.553 | 46,906.211 | 54,064.443 | 50,217.495 | 67,286.881 | 54,648.893 | 49,255.435 | 43,393.211 | 47,150.989 |
| Inventory
| 90,585.424 | 70,664.25 | 57,442.77 | 57,669.877 | 62,173.361 | 62,312.499 | 53,494.316 | 47,964.422 | 47,568.951 | 49,522.277 | 43,107.463 |
| Other Current Assets
| 2,917.002 | 3,731.089 | 1,462.807 | 2,299.922 | 4,535.689 | 4,877.667 | 6,903.271 | 3,382.162 | 1,817.51 | 7,788.168 | 1,973.809 |
| Total Current Assets
| 151,941.082 | 135,902.171 | 116,325.65 | 111,166.321 | 138,192.492 | 124,176.49 | 128,936.315 | 110,638.039 | 102,226.92 | 105,108.13 | 97,476.89 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 99,852.452 | 96,073.291 | 93,918.545 | 95,677.138 | 90,100.147 | 90,390.833 | 76,497.132 | 78,497.115 | 83,949.07 | 74,892.236 | 55,285.405 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 4,007.746 | 3,640.573 | 3,221.057 | 3,354.766 | 3,090.536 | 3,482.441 | 2,499.412 | 2,584.179 | 3,350.632 | 1,644.205 | 2,068.775 |
| Goodwill and Intangible Assets
| 4,007.746 | 3,640.573 | 3,221.057 | 3,354.766 | 3,090.536 | 3,482.441 | 2,499.412 | 2,584.179 | 3,350.632 | 1,644.205 | 2,068.775 |
| Long Term Investments
| 9,889.845 | 13,676.287 | 11,944.769 | 16,601.8 | 3,531.105 | 9,148.491 | 2,986.824 | 2,543.325 | 0 | 0 | 0 |
| Tax Assets
| 13,565.469 | 0 | 11,950.676 | 10,179.128 | 7,608.622 | 10,618.485 | 10,703.31 | 10,606.74 | 9,584.193 | 9,788.556 | 10,349.783 |
| Other Non-Current Assets
| 4,630.061 | 17,012.695 | 3,184.245 | 0 | 10,716.274 | 0.001 | -0 | -0 | 4,625.165 | 4,055.331 | 2,853.708 |
| Total Non-Current Assets
| 131,945.574 | 130,402.846 | 124,219.293 | 125,812.832 | 115,046.684 | 113,640.251 | 92,686.677 | 94,231.36 | 101,509.059 | 90,380.328 | 70,557.671 |
| Total Assets
| 283,886.656 | 266,305.017 | 240,544.943 | 236,979.153 | 253,239.177 | 237,816.742 | 221,622.993 | 204,869.399 | 203,735.98 | 195,488.457 | 168,034.561 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 14,951.374 | 22,775.302 | 14,742.474 | 16,404.016 | 14,293.367 | 15,296.391 | 15,020.329 | 15,450.647 | 15,716.878 | 16,602.104 | 18,288.508 |
| Short Term Debt
| 90,390.042 | 74,262.254 | 64,270.589 | 56,110.792 | 62,073.522 | 54,512.1 | 42,120.856 | 28,375.875 | 41,082.535 | 34,090.028 | 37,277.959 |
| Tax Payables
| 86.851 | 118.339 | 166.283 | 0 | 976.157 | 0 | 1,577.182 | 5,788.041 | 1,441.06 | 2,631.288 | 17,554.561 |
| Deferred Revenue
| 0 | 0 | 179.998 | 14,968.962 | 16,129.25 | 13,363.526 | 1,577.182 | 16,552.875 | 15,917.417 | 13,850.059 | 30,049.149 |
| Other Current Liabilities
| 27,232.147 | 21,105.366 | 16,209.662 | 16,299.348 | 16,420.512 | 642.935 | 10,599.497 | 10,764.833 | 14,476.357 | 11,218.771 | 12,494.588 |
| Total Current Liabilities
| 132,660.414 | 118,261.261 | 95,569.006 | 88,814.156 | 93,763.557 | 83,814.952 | 69,317.865 | 60,379.395 | 72,716.83 | 64,542.191 | 85,615.616 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 1,042.638 | 1,674.044 | 241.582 | 475.747 | 1,191.886 | 1,910.228 | 451.1 | 451.1 | 0 | 5,000 | 10,000 |
| Deferred Revenue Non-Current
| 0 | 0 | -2,349.18 | -2,188.604 | -4,181.472 | -2,105.912 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 2,349.18 | 2,188.604 | 4,181.472 | 2,105.912 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 4,029.582 | 1,988.291 | 1,030.299 | 1,988.52 | 2,226.94 | 2,928.057 | 2,841.863 | 2,529.307 | 1,616.81 | 3,129.116 | 4,089.089 |
| Total Non-Current Liabilities
| 5,072.22 | 3,662.334 | 1,271.881 | 2,464.267 | 3,418.826 | 4,838.286 | 3,292.963 | 2,980.407 | 1,616.81 | 8,129.116 | 14,089.089 |
| Total Liabilities
| 137,732.634 | 121,923.596 | 96,840.887 | 91,278.423 | 97,182.383 | 88,653.237 | 72,610.828 | 63,359.803 | 74,333.64 | 72,671.307 | 99,704.705 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 11,953.43 | 11,953.43 | 11,953.43 | 11,953.43 | 11,953.43 | 11,953.43 | 11,953.43 | 11,953.43 | 11,953.43 | 11,953.43 | 10,758.085 |
| Retained Earnings
| 98,332.771 | 96,032.57 | 94,695.438 | 94,587.473 | 104,207.442 | 93,325.506 | 93,602.255 | 90,122.029 | 77,090.268 | 70,137.655 | 51,042.767 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 1,991.59 | 3,976.697 | 4,473.721 | 3,817.327 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 35,867.821 | 36,395.421 | 40,067.242 | 39,159.828 | 39,895.921 | 43,884.568 | 43,456.48 | 39,434.136 | 40,358.642 | 40,726.066 | 6,529.004 |
| Total Shareholders Equity
| 146,154.022 | 144,381.421 | 143,704.056 | 145,700.731 | 156,056.793 | 149,163.504 | 149,012.166 | 141,509.596 | 129,402.34 | 122,817.151 | 68,329.856 |
| Total Equity
| 146,154.022 | 144,381.421 | 143,704.056 | 145,700.731 | 156,056.793 | 149,163.504 | 149,012.166 | 0 | 0 | 0 | 0 |
| Total Liabilities & Shareholders Equity
| 283,886.656 | 266,305.017 | 240,544.943 | 236,979.154 | 253,239.176 | 237,816.742 | 221,622.993 | 204,869.398 | 203,735.98 | 195,488.458 | 168,034.561 |